The Duke Funding Alert newsletter, published every Monday, provides information on all new and updated grants and fellowships added to the database during the prior week. This listserv is restricted to members of the Duke community.
Notice of Special Interest (NOSI): Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3) (Clinical Trial Optional) for Advancing Recruitment through Trial Innovation Network (AR-TIN)
The purpose of this Notice of Special Interest (NOSI) is to expand the list of current CTSA Program research priority areas described in PAR-22-167.
This NOSI invites applications to design, develop, demonstrate, implement, and evaluate innovative tools and resources that will (1) transform, increase, and improve the recruitment of participants in clinical trials and (2) improve the use of participant-based information that will inform safety and efficacy for improving participants recruitment in clinical trials.
Award recipients are expected to work collaboratively with members of the Clinical and Translational Science Award (CTSA) Program and the Trial Innovation Network (TIN), while also engaging the broader CTSA community, to achieve individual and consortium goals and objectives. Successful applicants, funded via this NOSI, will become members of the TIN, have members that are part of the TIN Network Executive Committee (NEC), and adhere to its governance model.
This notice applies to due dates on or after October 17, 2023 and subsequent receipt dates through October 18, 2024.
Application Due Date(s): Oct 17, 2023; Feb 15, 2024; June 18, 2024; Oct 17, 2024